Kissei Pharmaceutical Co., Ltd.
TSE:4547.T
Overview | Financials
Company Name | Kissei Pharmaceutical Co., Ltd. |
Symbol | 4547.T |
Currency | JPY |
Price | 3,490 |
Market Cap | 154,276,381,830 |
Dividend Yield | 2.63% |
52-week-range | 2,907 - 3,720 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yasuo Takehana |
Website | https://www.kissei.co.jp |
An error occurred while fetching data.
About Kissei Pharmaceutical Co., Ltd.
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products primarily in Japan. It offers Urief and Urief OD tablets for the treatment of dysuria; Glufast, Glubes, and Marizev tablets for type 2 diabetes; Darbepoetin Alfa BS and Epoetin Alfa BS injections for the treatment
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD